TP53 and cancer: The pro-proliferative effects of mortalin in cancer cells have been assigned, at least in part, to its binding with the tumour suppressor protein, p53 that results in its retention in the cytoplasm and inhibition of its transcriptional activation and control of centrosome duplication function [17–19].